XML 122 R110.htm IDEA: XBRL DOCUMENT v3.20.1
Financial Assets at Amortized Cost-Securities - Summary of Reconciliation of Expected Loss to Financial Assets at Amortized Cost - Securities, Segregated by Stages (Detail) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Stage 1 [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss R$ (223) R$ (76)
Gains / (Losses) 36 (82)
Purchases (38) (28)
Settlements 48 14
Transfer to Stage 2 74  
Cure from Stage 2 (75) (51)
Cure from Stage 3 (20)  
Expected loss (198) (223)
Stage 1 [member] | Corporate debt securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (219) (73)
Gains / (Losses) 24 (83)
Purchases (35) (26)
Settlements 46 14
Transfer to Stage 2 74  
Cure from Stage 2 (16) (51)
Cure from Stage 3 (20)  
Expected loss (146) (219)
Stage 1 [member] | Corporate debt securities [member] | Rural product note [Member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (7) (9)
Gains / (Losses) 4 5
Purchases (7) (7)
Settlements 1 4
Expected loss (9) (7)
Stage 1 [member] | Corporate debt securities [member] | Real estate receivables certificates [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (2) (9)
Gains / (Losses)   5
Purchases (4)  
Settlements 23 2
Cure from Stage 3 (19)  
Expected loss (2) (2)
Stage 1 [member] | Corporate debt securities [member] | Debentures [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (206) (52)
Gains / (Losses) 19 (93)
Purchases (21) (18)
Settlements 20 8
Transfer to Stage 2 74  
Cure from Stage 2 (16) (51)
Cure from Stage 3 (1)  
Expected loss (131) (206)
Stage 1 [member] | Corporate debt securities [member] | Eurobonds and others [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (2) (2)
Settlements 1  
Expected loss (1) (2)
Stage 1 [member] | Corporate debt securities [member] | Promissory notes [Member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (2) (1)
Gains / (Losses) 1  
Purchases (3) (1)
Settlements 1  
Expected loss (3) (2)
Stage 1 [member] | Colombia [member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (4) (3)
Gains / (Losses) 5 1
Purchases (3) (2)
Settlements 2  
Expected loss   (4)
Stage 1 [member] | Brazil [Member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Gains / (Losses) 7  
Cure from Stage 2 (59)  
Expected loss (52)  
Stage 2 [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (824) (368)
Gains / (Losses) 82 (26)
Purchases (2) (561)
Settlements 66 6
Transfer to Stage 1 75 51
Transfer to Stage 3 619 74
Cure from Stage 1 (74)  
Expected loss (58) (824)
Stage 2 [member] | Corporate debt securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (765) (303)
Gains / (Losses) 82 (32)
Purchases (2) (561)
Settlements 66 6
Transfer to Stage 1 16 51
Transfer to Stage 3 619 74
Cure from Stage 1 (74)  
Expected loss (58) (765)
Stage 2 [member] | Corporate debt securities [member] | Rural product note [Member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Gains / (Losses) (8) 11
Purchases (2) (22)
Transfer to Stage 3 5 11
Expected loss (5)  
Stage 2 [member] | Corporate debt securities [member] | Real estate receivables certificates [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss   (5)
Gains / (Losses)   (1)
Transfer to Stage 3   6
Stage 2 [member] | Corporate debt securities [member] | Debentures [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (765) (284)
Gains / (Losses) 90 (30)
Purchases   (539)
Settlements 66 1
Transfer to Stage 1 16 51
Transfer to Stage 3 614 36
Cure from Stage 1 (74)  
Expected loss (53) (765)
Stage 2 [member] | Corporate debt securities [member] | Eurobonds and others [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Gains / (Losses)   (5)
Settlements   5
Stage 2 [member] | Corporate debt securities [member] | Other [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss   (14)
Gains / (Losses)   (7)
Transfer to Stage 3   21
Stage 2 [member] | Brazil [Member] | Government securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (59) (65)
Gains / (Losses)   6
Transfer to Stage 1 59  
Expected loss   (59)
Stage 3 [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (2,599) (4,738)
Gains / (Losses) (35) 742
Purchases (193) (594)
Settlements 1,029 2,065
Transfer to Stage 1 20  
Cure from Stage 2 (619) (74)
Expected loss (2,397) (2,599)
Stage 3 [member] | Corporate debt securities [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (2,599) (4,738)
Gains / (Losses) (35) 742
Purchases (193) (594)
Settlements 1,029 2,065
Transfer to Stage 1 20  
Cure from Stage 2 (619) (74)
Expected loss (2,397) (2,599)
Stage 3 [member] | Corporate debt securities [member] | Rural product note [Member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (173) (148)
Gains / (Losses) (3) (105)
Purchases (50) (36)
Settlements 198 127
Cure from Stage 2 (5) (11)
Expected loss (33) (173)
Stage 3 [member] | Corporate debt securities [member] | Real estate receivables certificates [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (361) (2,046)
Gains / (Losses) 16 447
Settlements 326 1,244
Transfer to Stage 1 19  
Cure from Stage 2   (6)
Expected loss   (361)
Stage 3 [member] | Corporate debt securities [member] | Debentures [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (2,037) (2,522)
Gains / (Losses) (48) 401
Purchases (127) (558)
Settlements 477 678
Transfer to Stage 1 1  
Cure from Stage 2 (614) (36)
Expected loss (2,348) (2,037)
Stage 3 [member] | Corporate debt securities [member] | Promissory notes [Member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (11) (22)
Gains / (Losses)   (5)
Settlements 11 16
Expected loss   (11)
Stage 3 [member] | Corporate debt securities [member] | Other [member]    
Disclosure of maturity analysis for derivative financial assets designated at fair value through profit or loss [Line Items]    
Expected loss (17)  
Gains / (Losses)   4
Purchases (16)  
Settlements 17  
Cure from Stage 2   (21)
Expected loss R$ (16) R$ (17)